125 related articles for article (PubMed ID: 15338953)
1. Transforming the TGFbeta pathway: convergence of distinct lead generation strategies on a novel kinase pharmacophore for TbetaRI (ALK5).
Singh J; Ling LE; Sawyer JS; Lee WC; Zhang F; Yingling JM
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):437-45. PubMed ID: 15338953
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
3. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
[TBL] [Abstract][Full Text] [Related]
4. Interactome of transforming growth factor-beta type I receptor (TbetaRI): inhibition of TGFbeta signaling by Epac1.
Conrotto P; Yakymovych I; Yakymovych M; Souchelnytskyi S
J Proteome Res; 2007 Jan; 6(1):287-97. PubMed ID: 17203972
[TBL] [Abstract][Full Text] [Related]
5. Pharmacophore modeling and virtual screening for the discovery of new transforming growth factor-beta type I receptor (ALK5) inhibitors.
Ren JX; Li LL; Zou J; Yang L; Yang JL; Yang SY
Eur J Med Chem; 2009 Nov; 44(11):4259-65. PubMed ID: 19640613
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
[TBL] [Abstract][Full Text] [Related]
7. Generation of mice with conditionally activated transforming growth factor beta signaling through the TbetaRI/ALK5 receptor.
Bartholin L; Cyprian FS; Vincent D; Garcia CN; Martel S; Horvat B; Berthet C; Goddard-Léon S; Treilleux I; Rimokh R; Marie JC
Genesis; 2008 Dec; 46(12):724-31. PubMed ID: 18821589
[TBL] [Abstract][Full Text] [Related]
8. Role of TGF-beta in cancer and the potential for therapy and prevention.
Kaklamani VG; Pasche B
Expert Rev Anticancer Ther; 2004 Aug; 4(4):649-61. PubMed ID: 15270668
[TBL] [Abstract][Full Text] [Related]
9. Altered primordial germ cell migration in the absence of transforming growth factor beta signaling via ALK5.
Chuva de Sousa Lopes SM; van den Driesche S; Carvalho RL; Larsson J; Eggen B; Surani MA; Mummery CL
Dev Biol; 2005 Aug; 284(1):194-203. PubMed ID: 15993878
[TBL] [Abstract][Full Text] [Related]
10. Compensatory signalling induced in the yolk sac vasculature by deletion of TGFbeta receptors in mice.
Carvalho RL; Itoh F; Goumans MJ; Lebrin F; Kato M; Takahashi S; Ema M; Itoh S; van Rooijen M; Bertolino P; Ten Dijke P; Mummery CL
J Cell Sci; 2007 Dec; 120(Pt 24):4269-77. PubMed ID: 18029401
[TBL] [Abstract][Full Text] [Related]
11. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
Yoo YA; Kang MH; Kim JS; Oh SC
Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
[TBL] [Abstract][Full Text] [Related]
12. Rapid generation of a high quality lead for transforming growth factor-beta (TGF-beta) type I receptor (ALK5).
Goldberg FW; Ward RA; Powell SJ; Debreczeni JE; Norman RA; Roberts NJ; Dishington AP; Gingell HJ; Wickson KF; Roberts AL
J Med Chem; 2009 Dec; 52(23):7901-5. PubMed ID: 19736928
[TBL] [Abstract][Full Text] [Related]
13. Three key residues underlie the differential affinity of the TGFbeta isoforms for the TGFbeta type II receptor.
De Crescenzo G; Hinck CS; Shu Z; Zúñiga J; Yang J; Tang Y; Baardsnes J; Mendoza V; Sun L; López-Casillas F; O'Connor-McCourt M; Hinck AP
J Mol Biol; 2006 Jan; 355(1):47-62. PubMed ID: 16300789
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
15. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
16. TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling.
König HG; Kögel D; Rami A; Prehn JH
J Cell Biol; 2005 Mar; 168(7):1077-86. PubMed ID: 15781474
[TBL] [Abstract][Full Text] [Related]
17. Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-beta type I receptor inhibitors.
Gellibert F; Woolven J; Fouchet MH; Mathews N; Goodland H; Lovegrove V; Laroze A; Nguyen VL; Sautet S; Wang R; Janson C; Smith W; Krysa G; Boullay V; De Gouville AC; Huet S; Hartley D
J Med Chem; 2004 Aug; 47(18):4494-506. PubMed ID: 15317461
[TBL] [Abstract][Full Text] [Related]
18. Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands.
Mazerbourg S; Hsueh AJ
Hum Reprod Update; 2006; 12(4):373-83. PubMed ID: 16603567
[TBL] [Abstract][Full Text] [Related]
19. Targeting TGFbeta-mediated processes in cancer.
Romano MF
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):253-63. PubMed ID: 19333871
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific efficacy of transforming growth factor-beta RI inhibition in Eker rats.
Laping NJ; Everitt JI; Frazier KS; Burgert M; Portis MJ; Cadacio C; Gold LI; Walker CL
Clin Cancer Res; 2007 May; 13(10):3087-99. PubMed ID: 17505012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
